Explore our Microsites

Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.


Oct 28, 2015

Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca's Patent Covering Fosladex Invalid

On October 15, 2015, Judge Caroline Somesom of the 31st Federal Court in Rio de Janeiro invalidated AstraZeneca's Brazilian patent No. PI0107445-8 covering Faslodex® (fulvestrant). Faslodex® is used to treat metastatic breast cancer in women who have gone through menopause. Specifically, a nullity lawsuit was filed in 2013 by Eurofarma Ltda, a Brazilian generic company, […]
back to top